Diisopropylethylamine → 5-(3-Trifluoromethyl-phenyl)-1-isopropyl-6-methyl-4-oxo-1,4-dihydro-pyridine-3-carboxylic acid 4-(N,N,N'-trimethylsulfamimidoyl)-benzylamide
Reaction equation
[CH:1]([N:4]1[C:9]([CH3:10])=[C:8]([C:11]2[CH:16]=[CH:15][CH:14]=[C:13]([C:17]([F:20])([F:19])[F:18])[CH:12]=2)[C:7](=[O:21])[C:6]([C:22](O)=[O:23])=[CH:5]1)([CH3:3])[CH3:2].CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[NH2:58][CH2:59][C:60]1[CH:65]=[CH:64][C:63]([S:66](=[N:71][CH3:72])([N:68]([CH3:70])[CH3:69])=[O:67])=[CH:62][CH:61]=1>CN(C=O)C.O>[CH3:69][N:68]([CH3:70])[S:66]([C:63]1[CH:64]=[CH:65][C:60]([CH2:59][NH:58][C:22]([C:6]2[C:7](=[O:21])[C:8]([C:11]3[CH:16]=[CH:15][CH:14]=[C:13]([C:17]([F:18])([F:20])[F:19])[CH:12]=3)=[C:9]([CH3:10])[N:4]([CH:1]([CH3:2])[CH3:3])[CH:5]=2)=[O:23])=[CH:61][CH:62]=1)(=[N:71][CH3:72])=[O:67]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 1-isopropyl-6-methyl-4-oxo-5-(3-trifluoromethyl-phenyl)-1,4-dihydro-pyridine-3-carboxylic acid (preparation 9.2, 186 mg, 0.55 mmol) in DMF (5 mL) is treated with DIPEA (300 μL, 1.72 mmol) and stirred at room temperature for 10 min. HBTU (312 mg, 0.82 mmol) is added, and the mixture is stirred for 20 min. A solution of 4-(aminomethyl)-N,N,N′-trimethylbenzenesulfonimidamide (preparation 60d, 156 mg, 0.69 mmol) in DMF (0.5 mL) is added and the mixture is stirred for 2 h. Water is added and the mixture is extracted with dichloromethane. The organic layer is dried over Na2SO4 and concentrated under reduced pressure. The residue is purified by preparative reversed phase HPLC (Xbridge, gradient of acetonitrile in water, 0.1% TFA). Yield: 41 mg (11% of theory); ESI mass spectrum: [M+H]+=549; r.t. HPLC: 1.17 min (Z001_005).
Workup
- stirringthe mixture is stirred for 20 min
- stirringthe mixture is stirred for 2 h
- extractionthe mixture is extracted with dichloromethane
- dry with materialThe organic layer is dried over Na2SO4
- concentrationconcentrated under reduced pressure
- customThe residue is purified by preparative reversed phase HPLC (Xbridge, gradient of acetonitrile in water, 0.1% TFA)
- customr.t
- custom1.17 min (Z001_005)
Sources & evidence
- ORD record
- ord-a4a71a1220a44db8bf4e3e9a58c37b2b
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09346794B1
Reaction notes
Loading…